Skip to main content

Advertisement

SpringerLink
Log in

HCC screening with non-contrast MRI and alpha-fetoprotein: combining a new player with an old friend

  • Commentary
  • Published:
European Radiology Aims and scope Submit manuscript

The Original Article was published on 18 July 2023

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Villanueva A (2019) Hepatocellular carcinoma. N Engl J Med 380(15):1450–1462

    Article  CAS  PubMed  Google Scholar 

  2. van Meer S, de Man RA, Coenraad MJ et al (2015) Surveillance for hepatocellular carcinoma is associated with increased survival: results from a large cohort in the Netherlands. J Hepatol 63:1156–1163

    Article  PubMed  Google Scholar 

  3. Singal AG, Nehra M, Adams-Huet B et al (2013) Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail? Am J Gastroenterol 108:425–432

    Article  PubMed  PubMed Central  Google Scholar 

  4. Gupta P, Soundararajan R, Patel A, Kumar-M P, Sharma V, Kalra N (2021) Abbreviated MRI for hepatocellular carcinoma screening: a systematic review and meta-analysis. J Hepatol 75(1):108–119. https://doi.org/10.1016/j.jhep.2021.01.041

    Article  PubMed  Google Scholar 

  5. Girardet R, Dubois M, Gibran M et al (2023) The combination of non-contrast abbreviated MRI and alpha-fetoprotein has high performance for hepatocellular carcinoma screening. Eur Radiol. https://doi.org/10.1007/s00330-023-09906-4

    Article  PubMed  Google Scholar 

  6. Kim JW, Lee CH, Kim KA et al (2023) Abbreviated MRI with second shot arterial phase for HCC evaluation: modified version of LI-RADS and recall reduction strategy. Eur Radiol 33:4401–4411. https://doi.org/10.1007/s00330-022-09348-4

    Article  PubMed  Google Scholar 

  7. Kanwal F, Singal AG (2019) Surveillance for hepatocellular carcinoma: current best practice and future direction. Gastroenterology 157:54–64

    Article  PubMed  Google Scholar 

  8. Son JH, Choi SH, Kim SY et al (2019) Validation of US liver imaging reporting and data system version 2017 in patients at high risk for hepatocellular carcinoma. Radiology 292(2):390–397. https://doi.org/10.1148/radiol.2019190035

  9. Park MK, Lee DH, Hur BY et al (2023) Effectiveness of US surveillance of hepatocellular carcinoma in chronic hepatitis B: US LI-RADS visualization score. Radiology 307(5):e222106. https://doi.org/10.1148/radiol.222106

  10. Bakker MF, de Lange SV, Pijnappel RM et al (2019) Supplemental MRI screening for women with extremely dense breast tissue. N Engl J Med 381(22):2091–2102. https://doi.org/10.1056/NEJMoa1903986

    Article  PubMed  Google Scholar 

Download references

Funding

The authors state that this work has not received any funding.

Author information

Authors and Affiliations

  1. Radiology Department, Centro Hospitalar Universitário de Santo António (CHUdSA), Porto, Portugal

    João Amorim

  2. School of Medicine, University of Minho, Braga, Portugal

    João Amorim

Authors
  1. João Amorim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to João Amorim.

Ethics declarations

Guarantor

The scientific guarantor of this publication is João Amorim.

Conflict of interest

The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

NA

Ethical approval

NA

Study subjects or cohorts overlap

NA

Methodology

• Commentary

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This comment refers to the article available at https://doi.org/10.1007/s00330-023-09906-4.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amorim, J. HCC screening with non-contrast MRI and alpha-fetoprotein: combining a new player with an old friend. Eur Radiol 33, 6927–6928 (2023). https://doi.org/10.1007/s00330-023-09934-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-023-09934-0

Search

Navigation